home / stock / piiiw / piiiw news
2024-05-11 06:05:20 ET P3 Health Partners Inc. (PIII) Q1 2024 Earnings Conference Call May 8, 2024 04:30 PM ET Company Participants Ryan Halsted - Gilmartin Group Sherif Abdou - Strategic Advisor Atul Kavthekar - CFO Amir Bacchus - CMO Aric Coffman - CEO ...
2024-03-28 22:04:09 ET P3 Health Partners Inc. (PIII) Q4 2023 Results Conference Call March 28, 2024 4:30 PM ET Company Participants Ryan Halsted - Gilmartin Group Sherif Abdou - Co-Founder, CEO Atul Kavthekar - CFO Amir Bacchus - CMO Bill Bettermann - CO...
P3 Health Partners Inc. (PIII) Q3 2022 Results Conference Call November 14, 2022 04:30 PM ET Company Participants Karen Blomquist - Vice President of Investor Relations Sherif Abdou - Chief Executive Officer Erin Darakjian - Interim Chief Financial Officer Am...
P3 Health Partners Inc. (PIII) Q2 2022 Earnings Conference Call October 20, 2022 04:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer Eric Atkins - Chief Financial Officer Amir Bacchus - ...
The following slide deck was published by P3 Health Partners Inc. in conjunction with this event. For further details see: P3 Health Partners (PIII) Investor Presentation - Slideshow
Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue expected to be up to $1 billion, a 56% increase vs. prior year At-risk Medicare Advantage members expected to be up 95,000 by end of full year 2022, a 42% increase vs. p...
HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company’s participation in the following inv...
News, Short Squeeze, Breakout and More Instantly...
P3 Health Partners Inc. Warrant Company Name:
PIIIW Stock Symbol:
NASDAQ Market:
P3 Health Partners Inc. Warrant Website:
Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue expected to be up to $1 billion, a 56% increase vs. prior year At-risk Medicare Advantage members expected to be up 95,000 by end of full year 2022, a 42% increase vs. p...
HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company’s participation in the following inv...